A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/48 (2006.01) A61K 9/52 (2006.01)
Patent
CA 2560995
The present invention relates generally to pharmaceutical dosage forms having immediate release and controlled release properties that contain a .gamma.- aminobutyric acid (GABAB) receptor agonist, e.g., baclofen, for the treatment of medical conditions, which includes spasms, cramping, and tightness of muscles, associated with ailments such as multiple sclerosis or certain spinal injuries.
La présente invention concerne d'une manière générale des formes galéniques pharmaceutiques à libération immédiate et contrôlée qui renferment un agoniste du récepteur de l'acide .gamma.-aminobutyrique (GABA<SB>B</SB>), tel que le baclofène, et qui servent au traitement d'états pathologiques tels que les spasmes, les crampes et la raideur musculaire associés à des affections telles que la sclérose en plaques ou certains traumatismes spinaux.
Han Chien-Hsuan
Hsiao Charles
Hsu Ann
Hsu Larry
Teng Ching-Ling Diana
Fetherstonhaugh & Co.
Impax Laboratories Inc.
LandOfFree
Controlled release dosage for gaba receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release dosage for gaba receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release dosage for gaba receptor agonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1689456